A signaling cascade of nuclear calcium-CREB-ATF3 activated by synaptic NMDA receptors defines a gene repression module that protects against extrasynaptic NMDA receptor-induced neuronal cell death and ischemic brain damage

Synapse-to-nucleus signaling triggered by synaptic NMDA receptors can lead to the buildup of a neuroprotective shield. Nuclear calcium activating the cAMP response element binding protein (CREB) plays a key role in neuroprotection acquired by synaptic activity. Here we show that in mouse hippocampal...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhang, Sheng-Jia (Author) , Buchthal, Bettina (Author) , Lau, David (Author) , Hayer, Stefanie Nicole (Author) , Dick, Oliver (Author) , Schwaninger, Markus (Author) , Veltkamp, Roland (Author) , Zou, Ming (Author) , Weiss, Ursula (Author) , Bading, Hilmar (Author)
Format: Article (Journal)
Language:English
Published: March 30, 2011
In: The journal of neuroscience
Year: 2011, Volume: 31, Issue: 13, Pages: 4978-4990
ISSN:1529-2401
DOI:10.1523/JNEUROSCI.2672-10.2011
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1523/JNEUROSCI.2672-10.2011
Verlag, lizenzpflichtig, Volltext: https://www.jneurosci.org/content/31/13/4978
Get full text
Author Notes:Sheng-Jia Zhang, Bettina Buchthal, David Lau, Stefanie Hayer, Oliver Dick, Markus Schwaninger, Roland Veltkamp, Ming Zou, Ursula Weiss, and Hilmar Bading
Description
Summary:Synapse-to-nucleus signaling triggered by synaptic NMDA receptors can lead to the buildup of a neuroprotective shield. Nuclear calcium activating the cAMP response element binding protein (CREB) plays a key role in neuroprotection acquired by synaptic activity. Here we show that in mouse hippocampal neurons, the transcription factor Atf3 (activating transcription factor 3) is a direct target of CREB. Induction of ATF3 expression by CREB in hippocampal neurons was initiated by calcium entry through synaptic NMDA receptors and required nuclear calcium transients and calcium/calmodulin-dependent protein kinase IV activity. Acting as a transcriptional repressor, ATF3 protects cultured hippocampal neurons from apoptosis and extrasynaptic NMDA receptor-induced cell death triggered by bath application of NMDA or oxygen-glucose deprivation. Expression of ATF3 in vivo using stereotaxic delivery of recombinant adeno-associated virus reduces brain damage following a cerebral ischemic insult in mice. Conversion of ATF3 to a transcriptional activator transforms ATF3 into a potent prodeath protein that kills neurons in cell culture and, when expressed in vivo in the hippocampus, ablates the neuronal cell layer. These results link nuclear calcium-CREB signaling to an ATF3-mediated neuroprotective gene repression program, indicating that activity-dependent shutoff of genes is an important process for survival. ATF3 supplementation may counteract age- and disease-related neuronal cell loss caused by a reduction in synaptic activity, malfunctioning of calcium signaling toward and within the nucleus (“nuclear calciopathy”), or increases in death signaling by extrasynaptic NMDA receptors.
Item Description:Gesehen am 16.01.2023
Physical Description:Online Resource
ISSN:1529-2401
DOI:10.1523/JNEUROSCI.2672-10.2011